» Articles » PMID: 33677126

Clinical Characteristics and Outcomes of COVID-19 Patients with Hypoxic Hepatitis

Citing Articles

Liver injury in COVID-19: an insight into pathobiology and roles of risk factors.

Tazarghi A, Bazoq S, Taziki Balajelini M, Ebrahimi M, Hosseini S, Nikoo H Virol J. 2024; 21(1):65.

PMID: 38491495 PMC: 10943793. DOI: 10.1186/s12985-024-02332-y.


COVID-19 and liver dysfunction in children: Current views and new hypotheses.

Yun Y, Feng Z, Zhang J World J Hepatol. 2023; 15(3):353-363.

PMID: 37034238 PMC: 10075013. DOI: 10.4254/wjh.v15.i3.353.


Prediction of 30-day mortality in heart failure patients with hypoxic hepatitis: Development and external validation of an interpretable machine learning model.

Sun R, Wang X, Jiang H, Yan Y, Dong Y, Yan W Front Cardiovasc Med. 2022; 9:1035675.

PMID: 36386374 PMC: 9649827. DOI: 10.3389/fcvm.2022.1035675.


Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study.

Yao H, Li H, Ma Z, Wu Y, Tang Y, Meng H Therap Adv Gastroenterol. 2022; 15:17562848221104365.

PMID: 35721837 PMC: 9201367. DOI: 10.1177/17562848221104365.